CAS 50932-19-9: Verminoside

Verminoside is a natural iridoid isolated from Kigelia africana, with anti-inflammatory and remarkable antioxidant activity.

Verminoside is a natural glycoside compound, which is derived from plant sources, particularly from the genus *Verbena* and *Buddleja*. It exhibits a range of pharmacological actions, primarily through its antioxidant and anti-inflammatory mechanisms. By scavenging free radicals and modulating inflammatory pathways, Verminoside effectively contributes to cellular protection and the mitigation of oxidative stress-induced damage. Research has shown that Verminoside has significant neuroprotective effects, making it a compound of interest in the study of neurological disorders. It is involved in the inhibition of pro-inflammatory cytokines, which are pivotal in the inflammatory response, thus potentially offering therapeutic value in conditions such as Alzheimer's disease and other neurodegenerative disorders. Additionally, its anti-bacterial and anti-viral properties extend its applicability in combating microbial infections. Ongoing studies continue to explore Verminoside's potential in various biomedical applications, focusing on its efficacy and molecular interaction pathways. The compound's plant-based origin further encourages its exploration as a potential natural therapeutic agent with minimal side effects compared to synthetic counterparts.